Lab tests may give 25%-30% of health-risk picture
The Nov. 9 AMA episode cautions that large test panels and biological-age scores may look precise without guiding decisions.

Peter Attia said in a Nov. 9 The Peter Attia Drive podcast episode that even comprehensive laboratory testing supplies “25-30ish percent” of the information needed to assess health risk.
The point matters for readers considering broad blood panels because lab results offer objective numbers and reference ranges, but Attia argued they should not be treated as a full measure of healthspan or disease risk.
Attia, host of The Peter Attia Drive, said on the podcast published Nov. 9, “So you always have to have that in the back of your mind, and that's much easier to evaluate when you have longitudinal data.” Longitudinal data means repeated measurements over time, rather than a single result viewed in isolation.
The episode, #415 and AMA #91, focuses on what blood work can contribute to decisions about longevity, chronic disease risk and organ health. The public podcast feed provides a preview for non-subscribers, while subscribers can access the full AMA through a private RSS feed or the show’s website.
Attia framed lab testing as useful but incomplete across major chronic diseases. The show notes list cardiovascular disease, metabolic dysfunction, cancer and neurodegenerative disease as areas where blood testing may help assess risk, while leaving gaps that require other forms of information.
Those gaps include imaging, body composition and functional testing, according to the episode summary. Attia also highlighted physical function, cognitive performance and emotional health as parts of healthspan that cannot be captured adequately through blood work alone.
The episode also cautioned against assuming that more testing produces better decisions. The show notes identify large direct-to-consumer panels, lipid subfractionation, biological-age scores and sleep scores as examples of sophisticated measures that may lack clear clinical actionability. Clinical actionability means the result can guide a meaningful next step.
Attia did not present the podcast as a substitute for medical care. His framework, as described in the episode materials, is to ask what a lab test measures, what it misses and whether the result can guide decisions in the context of a person’s broader risk picture.
Source: podcast episode, The Peter Attia Drive, Nov. 9, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Adults 50 to 64 reach 7.5% heavy-drinking rate
- Dinch exposure correlates with 27-gram lower birth weight
- British surgeons question rib remodelling after 3.7% complications
- Three weekly wall-squat sessions cut systolic blood pressure 13.73 mmHg in small trial
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

